Creyon Bio
Delivering RNA breakthroughs. Redefining hope.
31 employees · est. 2019 · San Diego, United States
MapLight Therapeutics, Inc.
Creating breakthrough innovative therapeutics for serious CNS disorders
144 employees · est. 2018 · Redwood City, United States
MapLight Therapeutics, Inc. is the older company (2019 vs 2018); MapLight Therapeutics, Inc. is the larger of the two.
Side-by-Side Comparison
| Metric | Creyon Bio | MapLight Therapeutics, Inc. |
|---|---|---|
| Founded | ||
| Founded | 2019 | 2018 older |
| Headquarters | ||
| Headquarters | San Diego, United States | Redwood City, United States |
| Employees | ||
| Employees | 31 | 144 larger |
| Industry | ||
| Industry | Biotechnology, Life Sciences | Biopharma, Biotechnology, Life Sciences |
| Funding Stage | ||
| Funding Stage | Series A | Series C |
| Total Funding | ||
| Total Funding | $40.00M | $268.10M |
| Funding Rounds | ||
| Funding Rounds | 1 | 4 |
| Services | ||
| Services | RNA therapy development, Tissue-specific delivery, CNS indication support, Splice-switching oligonucleotide therapy, Nucleic acid therapeutics | Discovery Platform Development, Innovative Therapeutic Development, Clinical Trials for CNS Conditions, Strategic Collaborations for New Treatments |
| Target Customers | ||
| Target Customers | Pharmaceutical companies, Biotech researchers, Healthcare providers, Patients with immune-driven diseases, Patients with CNS and neuromuscular conditions | Patients with Brain Disorders, Healthcare Providers, Research Institutions, Investors in Biotechnology |
| Taxonomy | ||
| Taxonomy | RNA Drug Design, AI-driven Drug Development, Nucleic Acid Therapies, Tissue-specific Delivery, Neuromuscular Disorders, Central Nervous System Disorders, Immunology Disorders, Tissue Biology, Computational Drug Design, Precision Medicine, Machine Learning In Drug Development, Precision Oligonucleotide-based Medicines, Pre-clinical Stage, Patient-centered Therapies, Data-driven Drug Development | Biopharmaceutical, Innovative Therapeutics, CNS Disorders, Central Nervous System, Drug Discovery, Single-cell Transcriptomics, Optogenetics, Novel Drug Targets, Brain Disorders, Therapeutic Development, Biotech Platform, Neurology, Precision Medicine, Drug Development |
| Website | ||
| Website | creyonbio.com | maplightrx.com |
About Creyon Bio
Creyon Bio, founded in 2019, is at the forefront of RNA drug design, operating within the Biotechnology and Life Sciences industries. Headquartered in the United States, Creyon aims to transform the therapeutic landscape with its AI-driven approach to crafting tissue-specific, RNA-targeted nucleic a...
About MapLight Therapeutics, Inc.
MapLight Therapeutics, Inc., established in 2018, is a promising player in the biopharmaceutical arena, focused on developing breakthrough innovations for serious central nervous system (CNS) disorders. Known for its commitment to transformative therapies, the company's core mission aligns with its...
We will tell you when either one moves
BounceWatch watches Creyon Bio and MapLight Therapeutics, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Creyon Bio and MapLight Therapeutics,... — by email.
Frequently Asked Questions
Compare Creyon Bio with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Creyon Bio on 15 Jun 2026, and MapLight Therapeutics, Inc. on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
